
Werewolf Therapeutics (HOWL) P/E Ratio
P/E Ratio as of Jun 30, 2025: -0.66
Average-0.7590
Median-0.7550
Minimum-0.8700
Maximum-0.6200
-0.66
Past Month+0.08 (10.81%)
The P/E ratio for Werewolf Therapeutics (HOWL) is -0.66 as of Jun 30, 2025. This represents a decrease of -44.07% compared to its 12-month average P/E ratio of -1.18. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Werewolf Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Werewolf Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Werewolf Therapeutics to industry peers.
Werewolf Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Werewolf Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Werewolf Therapeutics to industry peers.
Werewolf Therapeutics (HOWL) P/E Ratio Insights
See Werewolf Therapeutics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Werewolf Therapeutics (HOWL)
Order type
Buy in
Order amount
Est. shares
0 shares
Werewolf Therapeutics (HOWL) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $1.20 | -0.73 |
May 1, 2025 | $0.8709 | -0.54 |
Apr 1, 2025 | $0.8705 | -0.54 |
Mar 3, 2025 | $1.14 | -0.76 |
Feb 3, 2025 | $1.37 | -0.92 |
Jan 2, 2025 | $1.56 | -1.04 |
Werewolf Therapeutics (HOWL) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.66 | -33.33% |
2024 | -0.99 | -71.55% |
2023 | -3.48 | +262.50% |
2022 | -0.96 | +585.71% |
2021 | -0.14 | — |
FAQs About Werewolf Therapeutics (HOWL) P/E ratio
The latest P/E ratio of Werewolf Therapeutics (HOWL) is -0.66, as of Jun 30, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Werewolf Therapeutics’s last 12-month average P/E ratio is -1.18, compared to its current P/E ratio of -0.66. This reflects a decrease of -44.07%.
Werewolf Therapeutics’s current P/E ratio of -0.66 is lower than its last 12-month average P/E of -1.18. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Werewolf Therapeutics’s average P/E ratio over the last 3 years is -2.18. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Werewolf Therapeutics’s average P/E ratio over the last 5 years is -1.37. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.